Aristotle University Of Thessaloniki (AUTH)
Advancing chemical risk assessment through in silico new approach methodologies (NAMs): a quantitative adverse outcome network (qAON) framework linking perfluorooctanoic acid (PFOA) exposure to cardiovascular disease (CVD)-relevant mechanisms
Abstract
dc:descriptionThis thesis develops and applies an integrated source-to-outcome New Approach Methodology (NAM) framework for the quantitative assessment of industrial and health risks associated with perfluorooctanoic acid (PFOA), using Gendorf Chemical Park and the surrounding Altötting region as the case study. The framework connects acute process safety, historical emissions, environmental transport, external exposure, internal dosimetry, molecular perturbation, population-level associations, and adverse-outcome-relevant progression within a single assessment chain. It integrates quantitative risk assessment, atmospheric dispersion and multimedia fate modelling, probabilistic exposure reconstruction, physiologically based pharmacokinetic (PBPK) modelling, human biomonitoring, liver transcriptomics, survey-weighted NHANES analysis, adverse outcome pathway (AOP) development, quantitative in vitro-to-in vivo extrapolation (QIVIVE), and quantitative adverse outcome network (qAON) modelling. For acute process safety, the governing 600-second tetrafluoroethylene release under stable, low-wind conditions produced a maximum lower flammability limit distance of 1,617 m. The highest displayed location-specific risk contour, 1 × 10⁻⁶ per year, remained confined to the modelled process and storage area. For chronic PFOA exposure, groundwater was identified as the dominant long-term exposure-relevant compartment, while soil acted as a persistent secondary reservoir. Across 10,000 Monte Carlo simulations, the median cumulative external dose was 191.87 µg/kg and the median lifetime-average daily dose was 0.006571 µg/kg/day. Drinking water accounted for 84.35% of exposure, followed by diet at 14.01% and inhalation at 1.21%. PBPK modelling translated reconstructed exposure histories into serum concentrations and was evaluated against human biomonitoring data. The measured median serum concentration declined from 23.18 µg/L in 2018 to 10.00 µg/L in 2022, a 57% reduction closely aligned with the 63% modelled reduction. Integrated mechanistic and population evidence did not support hepatic steatosis as the primary adverse outcome. Instead, it supported a liver-centred pathway involving hepatobiliary regulation, bile-acid and sterol homeostasis, atherogenic lipid-risk signalling, and atherosclerosis-relevant vascular biology. A PFOA plaque-progression qAON was constructed by linking transcriptomic key-event functions, PBPK/QIVIVE dose translation, AOP-informed relationships, and a dynamic cholesterol–atherosclerosis model. The framework derived a serum/plasma screening threshold of 9 µg/L. Under the protective strong key-event-relationship scenario, this concentration corresponded to approximately one month earlier attainment of a normalized plaque-progression milestone over a 40-year horizon. Historical exposure from 1969 to 2018 produced a median advancement of 84.34 days, while residual burden from 2018 to 2040 produced 11.60 days, equivalent to 13.8% of the historical burden. These outputs quantify relative changes within a normalized plaque-progression model and do not represent individual cardiovascular event probabilities or clinical predictions. Overall, the thesis establishes a human-relevant, internal-dose-anchored, mechanism-based framework for Next Generation Risk Assessment and Safe and Sustainable by Design, with demonstrated value for regulatory screening, chemical prioritization, biomonitoring interpretation, and safer substitution without generating new in vivo animal data.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2026
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Karakoltzidis, Achilleas
- Καρακολτζίδης, Αχιλλέας
Subjects
dc:subject × 21- Αξιολόγηση Χημικού Κινδύνου
- Νέες Μεθοδολογίες Προσέγγισης (NAMs)
- Υπερφθοροοκτανοϊκό Οξύ (PFOA)
- Ποσοτικό Δίκτυο Δυσμενούς Έκβασης (qAON)
- Chemical Risk Assessment
- New Approach Methodologies (NAMs)
- Perfluorooctanoic Acid (PFOA)
- Quantitative Adverse Outcome Network (qAON)
- Επιστήμη Χημικού Μηχανικού
- Επιστήμες Μηχανικού και Τεχνολογία
- Χημική μηχανική
- Επιστήμες Υγείας
- Ιατρική και Επιστήμες Υγείας
- Δημόσια/περιβαλλοντική υγεία και Υγεία της εργασίας
- Πρωτοβάθμια φροντίδα υγείας
- Chemical Engineering
- Engineering and Technology
- Health Sciences
- Medical and Health Sciences
- Public Health, Environmental and Occupational Health
- Primary Health Care
Rights
- Language dc:language
- eng
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/62350